252 related articles for article (PubMed ID: 27899452)
1. Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.
Giménez-Mascarell P; Oyenarte I; Hardy S; Breiderhoff T; Stuiver M; Kostantin E; Diercks T; Pey AL; Ereño-Orbea J; Martínez-Chantar ML; Khalaf-Nazzal R; Claverie-Martin F; Müller D; Tremblay ML; Martínez-Cruz LA
J Biol Chem; 2017 Jan; 292(3):786-801. PubMed ID: 27899452
[TBL] [Abstract][Full Text] [Related]
2. The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis.
Hardy S; Uetani N; Wong N; Kostantin E; Labbé DP; Bégin LR; Mes-Masson A; Miranda-Saavedra D; Tremblay ML
Oncogene; 2015 Feb; 34(8):986-95. PubMed ID: 24632616
[TBL] [Abstract][Full Text] [Related]
3. The emerging roles and therapeutic potential of cyclin M/CorC family of Mg
Funato Y; Miki H
J Pharmacol Sci; 2022 Jan; 148(1):14-18. PubMed ID: 34924118
[TBL] [Abstract][Full Text] [Related]
4. Phosphocysteine in the PRL-CNNM pathway mediates magnesium homeostasis.
Gulerez I; Funato Y; Wu H; Yang M; Kozlov G; Miki H; Gehring K
EMBO Rep; 2016 Dec; 17(12):1890-1900. PubMed ID: 27856537
[TBL] [Abstract][Full Text] [Related]
5. Mg2+-dependent interactions of ATP with the cystathionine-β-synthase (CBS) domains of a magnesium transporter.
Hirata Y; Funato Y; Takano Y; Miki H
J Biol Chem; 2014 May; 289(21):14731-9. PubMed ID: 24706765
[TBL] [Abstract][Full Text] [Related]
6. PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3.
Zhang H; Kozlov G; Li X; Wu H; Gulerez I; Gehring K
Sci Rep; 2017 Mar; 7(1):48. PubMed ID: 28246390
[TBL] [Abstract][Full Text] [Related]
7. PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.
Kozlov G; Funato Y; Chen YS; Zhang Z; Illes K; Miki H; Gehring K
J Biol Chem; 2020 Aug; 295(33):11682-11692. PubMed ID: 32571875
[TBL] [Abstract][Full Text] [Related]
8. Structural Insights into the Intracellular Region of the Human Magnesium Transport Mediator CNNM4.
Giménez-Mascarell P; Oyenarte I; González-Recio I; Fernández-Rodríguez C; Corral-Rodríguez MÁ; Campos-Zarraga I; Simón J; Kostantin E; Hardy S; Díaz Quintana A; Zubillaga Lizeaga M; Merino N; Diercks T; Blanco FJ; Díaz Moreno I; Martínez-Chantar ML; Tremblay ML; Müller D; Siliqi D; Martínez-Cruz LA
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842432
[TBL] [Abstract][Full Text] [Related]
9. Current Structural Knowledge on the CNNM Family of Magnesium Transport Mediators.
Giménez-Mascarell P; González-Recio I; Fernández-Rodríguez C; Oyenarte I; Müller D; Martínez-Chantar ML; Martínez-Cruz LA
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845649
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3.
Kozlov G; Cheng J; Ziomek E; Banville D; Gehring K; Ekiel I
J Biol Chem; 2004 Mar; 279(12):11882-9. PubMed ID: 14704153
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PRL-2·CNNM3 Protein Complex Formation Decreases Breast Cancer Proliferation and Tumor Growth.
Kostantin E; Hardy S; Valinsky WC; Kompatscher A; de Baaij JH; Zolotarov Y; Landry M; Uetani N; Martínez-Cruz LA; Hoenderop JG; Shrier A; Tremblay ML
J Biol Chem; 2016 May; 291(20):10716-25. PubMed ID: 26969161
[TBL] [Abstract][Full Text] [Related]
12. The cyclic nucleotide-binding homology domain of the integral membrane protein CNNM mediates dimerization and is required for Mg
Chen YS; Kozlov G; Fakih R; Funato Y; Miki H; Gehring K
J Biol Chem; 2018 Dec; 293(52):19998-20007. PubMed ID: 30341174
[TBL] [Abstract][Full Text] [Related]
13. Burst kinetics and CNNM binding are evolutionarily conserved properties of phosphatases of regenerating liver.
Fakih R; Goldstein RH; Kozlov G; Gehring K
J Biol Chem; 2023 Apr; 299(4):103055. PubMed ID: 36822330
[TBL] [Abstract][Full Text] [Related]
14. The double lives of phosphatases of regenerating liver: A structural view of their catalytic and noncatalytic activities.
Gehring K; Kozlov G; Yang M; Fakih R
J Biol Chem; 2022 Jan; 298(1):101471. PubMed ID: 34890645
[TBL] [Abstract][Full Text] [Related]
15. Physiological and oncogenic roles of the PRL phosphatases.
Hardy S; Kostantin E; Hatzihristidis T; Zolotarov Y; Uetani N; Tremblay ML
FEBS J; 2018 Nov; 285(21):3886-3908. PubMed ID: 29770564
[TBL] [Abstract][Full Text] [Related]
16. Localizing PRL-2 expression and determining the effects of dietary Mg(2+) on expression levels.
Gungabeesoon J; Tremblay ML; Uetani N
Histochem Cell Biol; 2016 Jul; 146(1):99-111. PubMed ID: 27015884
[TBL] [Abstract][Full Text] [Related]
17. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into regulation of CNNM-TRPM7 divalent cation uptake by the small GTPase ARL15.
Mahbub L; Kozlov G; Zong P; Lee EL; Tetteh S; Nethramangalath T; Knorn C; Jiang J; Shahsavan A; Yue L; Runnels L; Gehring K
Elife; 2023 Jul; 12():. PubMed ID: 37449820
[TBL] [Abstract][Full Text] [Related]
19. Magnesium-sensitive upstream ORF controls PRL phosphatase expression to mediate energy metabolism.
Hardy S; Kostantin E; Wang SJ; Hristova T; Galicia-Vázquez G; Baranov PV; Pelletier J; Tremblay ML
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2925-2934. PubMed ID: 30718434
[TBL] [Abstract][Full Text] [Related]
20. Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms.
Jeong DG; Kim SJ; Kim JH; Son JH; Park MR; Lim SM; Yoon TS; Ryu SE
J Mol Biol; 2005 Jan; 345(2):401-13. PubMed ID: 15571731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
